3P BIOTECH NORWAY AS: årsregnskap 2009 vs 2008
Shrank 11% on revenue, cash halved-plus
approved 2010-06-29; registry 2010-07-10; journal 2010 490493
Summary
What changed
Comparing Årsregnskap 2009 with 2008 for 3P BIOTECH NORWAY AS. Revenue 24.4k NOK → 21.7k NOK (-11.2%). Equity 71.4k NOK → 15.1k NOK.
On the constructive side: payroll decreased. Pressures included: revenue fell; equity eroded; cash fell.
Net tougher year on the published lines.
At a glance
Scorecard
What improved
-
↑
Payroll decreased
Salary cost 85.5k NOK → 28.9k NOK (350% → 133% of revenue). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 24.4k NOK to 21.7k NOK (-11.2% YoY). Calculated
-
↓
Equity eroded
Book equity 71.4k NOK → 15.1k NOK (equity ratio 58.4% → 11.6%). Calculated
-
↓
Cash fell
Bank deposits 85.5k NOK → 12.4k NOK (-85.5% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.96× → 0.11× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated